Gene · 2683
Papers1,884
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,884
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic reprogramming and M2 macrophage depletion define the microenvironment of adenomyosis. | Front Endocrinol (Lausanne) | 2025 | 41356013 | PubTator, text mining | PubMed |
| B4GALT1 and Wntless collaborate to block LRP5/6 translocation from Golgi to cell surface. | J Cell Biol | 2025 | 41182165 | PubTator, text mining | PubMed |
| Glycan synthesis with SpyCatcher-SpyTag immobilized Leloir-glycosyltransferases. | Appl Microbiol Biotechnol | 2025 | 41134379 | PubTator, text mining | PubMed |
| Differential O-glucose elongation on a specific EGF repeat within the canonical ligand-binding domain regulates DLL1/4-NOTCH1 signaling. | Proc Natl Acad Sci U S A | 2025 | 41129232 | PubTator, text mining | PubMed |
| Corrigendum to "The AKR1C3/AR-V7 Complex Maintains CRPC Tumour Growth by Repressing B4GALT1 Expression". | J Cell Mol Med | 2025 | 41108204 | PubTator, text mining | PubMed |
| A lipid metabolism and lysosome-based risk signature for prognosis and immune response prediction in uterine corpus endometrial carcinoma. | Front Genet | 2025 | 40988925 | PubTator, text mining | PubMed |
| Novel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions. | Int J Mol Sci | 2025 | 40943353 | PubTator, text mining | PubMed |
| Δ-Decanolactone targets PLIN2 and FABP3 in goat milk: Longitudinal multi-omics framework unravels structural destabilization and metabolic reprogramming from flavor fraud. | Food Res Int | 2025 | 40922195 | PubTator, text mining | PubMed |
| HIV-1 manipulates CD96 on CD4+ T cells to subvert antiviral immunity. | Sci Adv | 2025 | 40911682 | PubTator, text mining | PubMed |
| Discovery of compound 1105486 as a selective inhibitor of B4GALT1: potential for pancreatic cancer therapy. | Front Chem | 2025 | 40860122 | PubTator, text mining | PubMed |
| Control of Golgi- V-ATPase through Sac1-dependent co-regulation of PI(4)P and cholesterol. | Nat Commun | 2025 | 40841558 | PubTator, text mining | PubMed |
| A nomogram integrating mutation signatures and clinical features for prognostic stratification in bladder cancer. | Discov Oncol | 2025 | 40815405 | PubTator, text mining | PubMed |
| Crystal structure of the fungal mannosyltransferase Och1 reveals active site primed for N-glycan binding. | PLoS One | 2025 | 40743235 | PubTator, text mining | PubMed |
| Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activation. | PNAS Nexus | 2025 | 40735689 | PubTator, text mining | PubMed |
| Identification of glycolysis-related genes and analysis of potential prognostic clinical application in oral squamous cell carcinoma. | Transl Cancer Res | 2025 | 40687254 | PubTator, text mining | PubMed |
| Microbial community dynamics and functional potential during the natural fermentation of rose: A metagenomic and volatile compound analysis. | Enzyme Microb Technol | 2025 | 40570415 | PubTator, text mining | PubMed |
| Bioinformatics prediction and experimental verification identify B4GALT1 as a diagnostic biomarker of glioblastoma. | Int J Biol Macromol | 2025 | 40460949 | PubTator, text mining | PubMed |
| Diagnostic, prognostic, and immunological roles of FUT8 in lung adenocarcinoma and lung squamous cell carcinoma. | PLoS One | 2025 | 40373023 | PubTator, text mining | PubMed |
| Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. | Front Mol Biosci | 2025 | 40370521 | PubTator, text mining | PubMed |
| Cytosolic UDP-Gal biosynthetic machinery is required for dimerization of SLC35A2 in the Golgi membrane and its interaction with B4GalT1. | Front Mol Biosci | 2025 | 40230451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2683/papers?page=3